Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease

201448 citationsJournal Articlehybrid Open Access

Authors

Robert J. Hye · Kaiser Permanente San Diego Medical Center

Eric K. Peden · Methodist Hospital

Timothy P. O’Connor

Barry J. Browne · Renal Research Institute

Bradley S. Dixon · University of Iowa Hospitals and Clinics

Andres Schanzer · University of Massachusetts Chan Medical School

Stephen C. Jensik · Rush University Medical Center

Abstract

PRT-201 appeared safe. The primary efficacy end point was not met. However, both PRT-201 doses were associated with improved unassisted maturation. The 30-μg dose was associated with increased PP in the subset with RCF.

Topics & Keywords

Central Venous Catheters and Hemodialysis Vascular Malformations Diagnosis and Treatment Vascular Malformations and Hemangiomas

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Vascular Surgery

Volume 60, Issue 2, pp. 454-461.e1

DOI: 10.1016/j.jvs.2014.02.037

Field-Weighted Citation Impact: 13.13